Chong Kun Dang Holdings Corp. (KRX:001630)
47,900
-500 (-1.03%)
At close: Aug 12, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Medicine | 925.73B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Medicine Growth | 9.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -40.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 28.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 72.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 12.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -40.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 28.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 72.62B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 12.50% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Consolidated Adjustment | -40.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 64.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 38.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 12.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea | 836.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | 15.43% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia | 63.41B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Asia Growth | -16.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe | 48.70B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Europe Growth | -13.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East | 11.17B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Middle East Growth | -13.45% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment | -40.60B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Consolidated Adjustment Growth | 64.11% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 38.71B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 12.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|